Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Ecotoxicology and Environmental Safety|September 28, 2013
Protozoans as indicators of sequential batch processes for phenol treatment; an autoecological approachC A Papadimitriou, D Petridis, A I Zouboulis, et al.
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|July 5, 2005
Comparison of several toxicity tests applied to complex wastewaters and mussel biomarkers in receiving watersOya S Okay, Leyla Tolun, Vildan Tüfekçi, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|October 9, 2009
Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver diseaseM Friedrich-Rust, A Schwarz, M Ong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2009
Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up?U Petrausch, P Samaras, P Veit-Haibach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2010
Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapyU Petrausch, P Samaras, S R Haile, et al.
Annals of Surgical Oncology|July 20, 2016
Short Chemotherapy-Free Interval Improves Oncological Outcome in Patients Undergoing Two-Stage Hepatectomy for Colorectal Liver MetastasesP Kambakamba, M Linecker, F A Alvarez, et al.
Blood Cancer Journal|August 29, 2019
Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)F Hitz, M Kraus, T Pabst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2016
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)D Koeberle, J-F Dufour, G Demeter, et al.
Pageof 4